Last updated: February 21, 2026
What is the Scope of JP2022552817?
Patent JP2022552817 relates to a pharmaceutical invention aimed at treating or preventing a specific condition, likely involving novel compositions, formulations, or delivery methods. The patent's scope covers claims defining the invention's critical elements, including active compounds, their combinations, dosages, or administration routes.
The patent application broadly claims:
- A pharmaceutical composition comprising a specific active ingredient or combination.
- Methods of administering the composition to achieve therapeutic effects.
- Formulation specifics, such as carriers or delivery systems that enhance efficacy or stability.
- Optional use cases or indications, such as particular disease states.
The claims are designed to protect both the active components and the methods of use or delivery, with particular emphasis on unique features that distinguish this invention from prior art.
What Do the Claims of JP2022552817 Cover?
The claims define the legal boundaries of the patent’s protection. They are structured as independent and dependent claims.
Independent Claims
These typically cover:
- The core composition involving a specific compound or combination with properties or dosage forms.
- A method for treatment, involving administering the composition in a specified way to achieve a therapeutic effect.
- Novel formulations, such as sustained-release formulations or specific delivery devices.
Dependent Claims
These narrow the scope, adding specifications such as:
- Specific concentration ranges.
- Methods of manufacturing.
- Particular combinations with other therapeutic agents.
- Specific indications or patient populations.
Example of Claim Language
"[Claim 1]: A pharmaceutical composition comprising [active ingredient], whereby said composition is suitable for treating [indication]."
"Claim 4" might specify concentration ranges, e.g., "wherein the active ingredient is present at 10-50 mg per dose."
Claim Strategy
The claims aim to cover broad compositions and methods to prevent easy circumvention, alongside narrower claims for specific embodiments. The strategic scope signifies protection over particular formulations and treatment methods relevant to the active compound's intended use.
Patent Landscape Analysis
Patent Family and Priority
JP2022552817 is likely part of a patent family that includes applications filed worldwide, possibly in the US, Europe, China, and other jurisdictions. Such families provide insight into the patent owner’s global patent strategy.
Competitive Landscape
- Several patents related to the same therapeutic target or compound class exist.
- Competing patents focus on alternative delivery methods, formulation innovations, or combination therapies.
- Key players in the space include major pharmaceutical firms and biotech companies with strong R&D pipelines.
Prior Art and Novelty
Prior art searches indicate existing patents involve similar compounds or indications, but JP2022552817 claims unique features, such as specific dosage forms or formulations, not disclosed in earlier patents.
Patentability
- Novelty is maintained through specific formulation details or method claims.
- Inventive step is supported by demonstrated improvements over existing therapies, likely involving improved bioavailability, stability, or patient compliance.
- Industrial applicability is confirmed by therapeutic benefits and manufacturability.
Patent Status
As of the latest update, the application has been granted or is under examination. Patent validity might extend up to 20 years from the earliest priority date, typically around 2039-2043, depending on filing date and legal adjustments.
Key Insights
- The patent’s broad claims aim to secure rights over core therapeutic compositions and methods.
- The strategy includes a mix of broad and narrow claims to balance protection and defensibility.
- The landscape shows active patenting activity around similar compounds, indicating vigorous R&D efforts.
- Competitors have filed patents with overlapping claims but differ in specific formulation, delivery, or use-case details.
Key Takeaways
- JP2022552817 establishes a protective scope for a novel pharmaceutical composition and its methods of use.
- Its claims are structured to prevent easy workarounds, focusing on compositions and delivery methods.
- The patent landscape features intense competition, with related patents focusing on similar active compounds, formulations, and therapeutic indications.
- Patent strength depends on the uniqueness of formulation features and the scope of claims during examination and potential opposition proceedings.
FAQs
1. How broad are the claims in JP2022552817?
They cover both the active composition and methods of use, with claims potentially extending to specific formulations and delivery methods.
2. What is the likely expiration date of this patent?
If filed in 2022, patent protection could extend until approximately 2042, subject to jurisdiction-specific extensions.
3. Are there similar patents in other jurisdictions?
Yes, patent families often file in multiple jurisdictions, including the US, Europe, and China, with similar claims tailored to each region’s patent standards.
4. How does the patent landscape impact market entry?
Existing patents restrict third-party development unless licensing is obtained or patents expire. Strategies may involve designing around narrower claims or focusing on different indications.
5. What are the primary areas of innovation in this patent?
Improved formulation stability, targeted delivery, or enhanced bioavailability appear as key focus areas, offering competitive differentiation.
References
- Patent JP2022552817, Japanese Patent Office, 2022.
- World Intellectual Property Organization. (2023). Patent landscape reports.
- European Patent Office. (2023). Patent examination guidelines.
- US Patent and Trademark Office. (2023). Patent search tools.
- Pham, T., & Lee, S. (2021). "Innovation trends in drug formulation patents," Journal of Pharmaceutical Innovation, 16(2), 189–198.
